George Thomas

George Thomas

Auto-generated profile, based on publicly available information

George Thomas

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2004 in Nature
Verified
Journal Article
Closed access
PDF file
SUSung Hee Um
Sung Hee Um
FFFrancesca Frigerio
Francesca Frigerio
MWMitsuhiro Watanabe
Mitsuhiro Watanabe
FPFrédéric Picard
Frédéric Picard
MJManel Joaquin
Manel Joaquin
GTGeorge Thomas
George Thomas

12 May 2006 in Science
Verified
Journal Article
Closed access
PDF file
DCDaniela Cota
Daniela Cota
KPKarine Proulx
Karine Proulx
KSKathi A. Blake Smith
Kathi A. Blake Smith
SKSara C. Kozma
Sara C. Kozma
GTGeorge Thomas
George Thomas
RSRandy J. Seeley
Randy J. Seeley
The mammalian Target of Rapamycin (mTOR) protein is a serine-threonine kinase that regulates cell-cycle progression and growth by sensing changes in energy status. We demonstrated that mTOR signaling plays a role in the brain mechanisms that respond to nutrient availability, regulating energy balance. In the rat, mTOR signaling is controlled by energy status in specific regions of the hypothalamus and colocalizes with neuropeptide Y and proopiomelanocortin neurons in the arcuate nucleus. Central administration of leucine increases hypothalamic mTOR signaling and decreases food intake and body weight. The hormone leptin increases hypothalamic mTOR activity, and the inhibition of mTOR signaling blunts leptin's anorectic effect. Thus, mTOR is a cellular fuel sensor whose hypothalamic activity is directly tied to the regulation of energy intake.

1 August 2008 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ACArkaitz Carracedo
Arkaitz Carracedo
LMLi Ma
Li Ma
JTJulie Teruya-Feldstein
Julie Teruya-Feldstein
FRFederico Rojo
Federico Rojo
LSLeonardo Salmena
Leonardo Salmena
PPPier Paolo Pandolfi
Pier Paolo Pandolfi
Numerous studies have established a causal link between aberrant mammalian target of rapamycin (mTOR) activation and tumorigenesis, indicating that mTOR inhibition may have therapeutic potential. In this study, we show that rapamycin and its analogs activate the MAPK pathway in human cancer, in what represents a novel mTORC1-MAPK feedback loop. We found that tumor samples from patients with biopsy-accessible solid tumors of advanced disease treated with RAD001, a rapamycin derivative, showed an administration schedule–dependent increase in activation of the MAPK pathway. RAD001 treatment also led to MAPK activation in a mouse model of prostate cancer. We further show that rapamycin-induced MAPK activation occurs in both normal cells and cancer cells lines and that this feedback loop depends on an S6K-PI3K-Ras pathway. Significantly, pharmacological inhibition of the MAPK pathway enhanced the antitumoral effect of mTORC1 inhibition by rapamycin in cancer cells in vitro and in a xenograft mouse model. Taken together, our findings identify MAPK activation as a consequence of mTORC1 inhibition and underscore the potential of a combined therapeutic approach with mTORC1 and MAPK inhibitors, currently employed as single agents in the clinic, for the treatment of human cancers.

2 October 2009 in Science
Verified
Journal Article
Closed access
PDF file
CSColin Selman
Colin Selman
JTJennifer M A Tullet
Jennifer M A Tullet
DWDaniela Wieser
Daniela Wieser
EIElaine Irvine
Elaine Irvine
SLSteven J. Lingard
Steven J. Lingard
DWDominic J. Withers
Dominic J. Withers
Mimicking Caloric Restriction: The extended life span and resistance to age-related diseases in animals exposed to caloric restriction has focused attention on the biochemical mechanisms that produce these effects. Selman et al. (p. 140 ; see the Perspective by Kaeberlein and Kapahi ) explored the role of the mammalian ribosomal protein S6 kinase 1 (S6K1), which regulates protein translation and cellular energy metabolism. Female knockout mice lacking expression of S6K1 showed characteristics of animals exposed to caloric restriction, including improved health and increased longevity. The beneficial effects included reduced fat mass in spite of increased food intake. Thus, inhibition of signaling pathways activated by S6K1 might prove beneficial in protecting against age-related disease.

1 June 2003 in Molecular Cell
Verified
Journal Article
Closed access
AGAttila Garami
Attila Garami
FZFried J.T Zwartkruis
Fried J.T Zwartkruis
TNTakahiro Nobukuni
Takahiro Nobukuni
MJManel Joaquin
Manel Joaquin
MRMarta Roccio
Marta Roccio
GTGeorge Thomas
George Thomas

1 May 2010 in Cell Metabolism
Verified
Journal Article
Closed access
AKAdem Kalender
Adem Kalender
ASAnand Selvaraj
Anand Selvaraj
SKSo Young Kim
So Young Kim
PGPawan Gulati
Pawan Gulati
SBSophie Brûlé
Sophie Brûlé
GTGeorge Thomas
George Thomas